Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
(Photo Illustration by Brendan Smialowski/Getty Images)
Health care products maker Johnson & Johnson is recalling another lot of Tylenol products due to a musty odor which has already triggered five other recalls of the company’s over-the-counter medicines.
The latest recall involves more than 34,000 bottles of Tylenol 8 Hour Extended Release, which were distributed throughout the U.S. All of the bottles are from a single lot. Get the full story »
Johnson & Johnson’s revenue has slumped for a second straight year, prompting its chief executive to make an extraordinary pitch to soothe investors and defend the company’s handling of 17 costly recalls.
The health care giant, hammered by the weak global economy, growing pricing pressures and recalls that have kept many popular nonprescription medicines off store shelves, reported Tuesday a 12 percent profit decline and a 5.5 percent drop in sales for the fourth quarter. Get the full story »
Johnson & Johnson, already under fire for a string of product recalls, has another public relations issue on its hands after its o.b. tampons temporarily disappeared from stores and little was said about what happened. Get the full story »
Johnson & Johnson recalled nearly 47 million units of over-the-counter medicines Friday, the latest in a string of quality-related product recalls.
J&J said the latest recall resulted from a thorough examination of manufacturing records that the company had undertaken in the wake of earlier recalls. J&J plans to continue reviewing practices at additional plants and signaled further recalls could result. Get the full story »
Johnson & Johnson is recalling yet another lot of over-the-counter Tylenol because of a musty or moldy smell. McNeil Consumer Healthcare business says it is recalling lot BCM155, or about 128,000 bottles, of Tylenol 8 Hour caplets that come in bottles with 50 pills. Get the full story »
Johnson & Johnson disclosed Wednesday that the health products giant has now received multiple subpoenas from federal prosecutors related to repeated recalls of Tylenol and other consumer health products. Get the full story »
Johnson & Johnson is expanding a recall of over-the-counter drugs including Tylenol and Motrin IB because of a musty or moldy smell.
The McNeil Consumer Healthcare business says it is recalling 21 lots of over-the-counter drugs sold in the U.S., Puerto Rico, Fiji, Guatemala, Dominican Republic, Trinidad and Tobago and Jamaica. Get the full story »
